XML 112 R57.htm IDEA: XBRL DOCUMENT v3.25.1
Note K - Segment and Geographic Data - Summary by Reporting and Operating Segments (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Product sales, net $ 8,629,928 $ 9,827,444
Cost of products sold 2,195,340 3,034,832
Gross Margin 6,434,588 6,792,612
Salaries & employee benefits 3,741,395 4,273,464
Stock-based compensation expense 1,345,122 1,467,426
Royalty expense 442,059 485,334
Marketing 560,895 755,170
Rent & occupancy costs 154,428 156,649
Consultants and professional services fees 3,354,591 3,110,115
Insurance 571,176 683,936
Warehousing expense 496,837 536,241
Regulatory expense 482,865 422,868
Travel expense 259,455 306,026
Research and development expenses 858,767 701,378
Depreciation and amortization expense 37,448 61,912
Other segment items 886,507 938,567
Total operating expenses 13,191,545 13,899,086
Operating income (loss) (6,756,957) (7,106,474)
Total assets 9,797,072 11,371,512
Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]    
Product sales, net 0 0
Cost of products sold 0 0
Gross Margin 0 0
Salaries & employee benefits 1,353,193 1,320,900
Stock-based compensation expense 1,343,044 1,444,545
Royalty expense 0 0
Marketing 31,526 103,768
Rent & occupancy costs 74,847 29,763
Consultants and professional services fees 2,284,403 1,741,528
Insurance 178,185 129,948
Warehousing expense 14,589 14,055
Regulatory expense 441,892 321,244
Travel expense 65,773 58,263
Research and development expenses 0 0
Depreciation and amortization expense 37,448 54,882
Other segment items 450,349 260,011
Total operating expenses 6,275,249 5,478,907
Operating income (loss) (6,275,249) (5,478,907)
Total assets 3,992,825 6,159,532
Dental Segment [Member]    
Product sales, net 8,527,108 9,761,444
Dental Segment [Member] | Operating Segments [Member]    
Product sales, net 8,527,108 9,761,444
Cost of products sold 2,186,142 2,731,426
Gross Margin 6,340,966 7,030,018
Salaries & employee benefits 1,559,933 1,790,678
Stock-based compensation expense 0 15,723
Royalty expense 436,828 482,034
Marketing 439,830 505,428
Rent & occupancy costs 48,973 65,793
Consultants and professional services fees 252,136 169,366
Insurance 203,648 287,253
Warehousing expense 448,190 470,079
Regulatory expense 24,614 68,338
Travel expense 98,334 127,787
Research and development expenses 835,851 614,952
Depreciation and amortization expense 0 4,243
Other segment items 416,587 347,740
Total operating expenses 4,764,924 4,949,414
Operating income (loss) 1,576,042 2,080,604
Total assets 5,359,734 4,866,786
Medical Segment [Member]    
Product sales, net 102,820 66,000
Medical Segment [Member] | Operating Segments [Member]    
Product sales, net 102,820 66,000
Cost of products sold 9,198 303,406
Gross Margin 93,622 (237,406)
Salaries & employee benefits 828,269 1,161,886
Stock-based compensation expense 2,078 7,158
Royalty expense 5,231 3,300
Marketing 89,539 145,974
Rent & occupancy costs 30,608 61,093
Consultants and professional services fees 818,052 1,199,221
Insurance 189,343 266,735
Warehousing expense 34,058 52,107
Regulatory expense 16,359 33,286
Travel expense 95,348 119,976
Research and development expenses 22,916 86,426
Depreciation and amortization expense 0 2,787
Other segment items 19,571 330,816
Total operating expenses 2,151,372 3,470,765
Operating income (loss) (2,057,750) (3,708,171)
Total assets $ 444,513 $ 345,194